2013 Analysis of the Global Blood Banking Market: Emerging Tests, Technology Assessment, Instrumentation Review, Sales Forecasts by Country, and Strategic Profiles of Leading Suppliers

February 2013 | 340 pages | ID: 229D863D49EEN
Venture Planning Group

Abstracts

This new 340-page report from Venture Planning Group provides analysis of the global blood banking market, including emerging tests, technologies, instrumentation, sales forecasts by country, and strategic profiles of leading suppliers.

The report presents:

• Estimated numbers of laboratories performing blood banking testing, as well as test volume and sales forecasts for France, Germany, Italy, Japan, Spain, U.K. and U.S.
• Comprehensive analysis of the clinical significance and market needs for major blood typing, grouping, and infectious disease screening assays, including NAT tests, as well as extensive listings of companies developing or marketing new blood banking technologies and products.
• Review of current instrumentation technologies, and features of leading blood banking automated and semi-automated analyzers.
• Assessments of molecular diagnostics, monoclonal and polyclonal antibodies, immunoassays, microtitration plates, IT, lasers, synthetic red cell substitutes, genetically engineered blood components, blood preservation, autologous blood transfusion/freezing technologies and their potential applications for blood banking testing.
• Profiles of current and emerging suppliers of blood banking products, including their sales, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements, and business strategies.

Contains 340 pages and 11 tables

Contents

I. BUSINESS ENVIRONMENT

II. MARKET STRUCTURE

III. MARKET SIZE AND GROWTH

IV. MAJOR BLOOD TYPING, GROUPING AND INFECTIOUS

DISEASE SCREENING TESTS

1. Blood Typing and Grouping Tests
  a. ABO
  b. Antibody Panels
  c. Antibody Screening
  d. Antigen Typing
  e. Antiglobulin Test
  f. Crossmatch
  g. HLA Typing
  h. Rh
  i. Other Blood Groups
2. Infectious Disease Screening Tests
  a. AIDS
    Structure and Composition
    Classification
    Origin of AIDS
    Animal Lentivirus Systems
    Virus Receptors
    HIV Infections in Humans
      Pathogenesis & Pathology
      Overview of Course of HIV Infection
    CD4T Lymphocytes and Memory Cells
    Monocytes and Macrophages
    Lymphoid Organs
    Neural Cells
    Viral Coinfections
      Clinical Findings
    Plasma Viral Load
    Pediactric AIDS
      Neurologic Disease
      Opportunistic Infections
      Protozoa
      Fungi
      Bacteria
    Viruses
    Cancer
    Immunity
    Laboratory Diagnosis
      Virus Isolation
      Serology
      Detection of Viral Nucleic Acid or Antigens
    Epidemiology
      Worldwide Spread of AIDS
      United States
      Routes of Transmission
    Prevention, Treatment, And Control
      Antiviral Drugs
      Vaccines Against HIV
    Transmission of HIV in Blood Products
    HIV Transmission in Transplant and

ARTIFICIAL INSEMINATION RECIPIENTS

    Diagnostic Tests
    Enzyme Immunoassay Interpretation
    Specificity, Sensitivity, and Predictive

VALUE OF ENZYME IMMUNOASSAY

    Competition Assays
    Western Blot Technique
    Immuno-Fluorescence Assay (IFA)
    Radioimmunoprecipitation
    HIV-1/HIV-2 Combination Testing
    Methods of HIV&-Antigen Detection
    Antigen Assays and Blood Screening
    Urine Tests
    DNA Probes
    Overview
    Quantitative Polymerase Chain Reaction
    In Situ PCR
    Needed Improvements
    Viral Load/Drug Resistance Testing
    Genotype and Phenotype Testing
    Blood Banking Considerations
  b. Hepatitis
    Hepatitis A
    Hepatitis B
      Structure and Composition
      Replication of Hepatitis B Virus
    Hepatitis C
    Hepatitis D (Delta Hepatitis)
    Hepatitis E
    Hepatitis G
    Hepatitis Virus Infections In Humans
      Pathology
    Clinical Findings
    Laboratory Features
      Hepatitis A
      Hepatitis B
      Hepatitis C
      Hepatitis D
      Hepatitis E
    Virus&n-Host Immune Reactions
    Epidemiology
      Hepatitis A
      Hepatitis B
      Hepatitis C
      Hepatitis D (Delta Agent)
    Vaccines and Drugs
  c. Cytomegalovirus
    Background
    Chorioretinitis
    Gastrointestinal
    Central Nervous System Disease
    Diagnostic Tests
    Vaccines and Drugs
  d. Syphilis
    Background
    Diagnostic Tests
    Vaccines and Drugs
  e. West Nile Virus
    Background
    Clinical Syndromes
    Diagnostic Tests
    Vaccines and Drugs
  f. Parvovirus B19
    Microbiology
    Epidemiology
    Clinical Syndromes
      Erythema Infectiosum Slapped (cheek)
      Adult Polyarthropathy
      Transient Aplastic Crisis
      Transient Pancytopenia
      Red Cell Aplasia in the Immunocompromised
      Perinatal Infections
    Diagnosis
    Treatment
  g. Creutzfeldt-Jakob’s Disease
    Background
    Transmission
    Diagnostic Tests
    Major Commercial and Academic Players
      Bayer
      Disease Sciences/BioTec Global
      Imperial College School of Medicine
      Ortho-Clinical Diagnostics
      Pall
      ProMetic Life Sciences
      Proteome Sciences/Idexx
      Q-One Biotech
      Serono
      U.S. Agricultural Research Service
    Drugs
    Vaccines
  h. Malaria
  i. Chagas Disease
  j. Babesiosis
3. Pathogen Reduction
4. Leukocyte Reduction
    Background
    Methods

V. INSTRUMENTATION REVIEW: OPERATING CHARACTERISTICS, FEATURES AND SELLING PRICES OF LEADING AUTOMATED AND SEMIAUTOMATED ANALYZERS MANUFACTURED BY ABBOTT, BECKMAN COULTER/DANAHER, BIO-RAD, BIOMERIEUX, GEN-PROBE/HOLOGIC, GRIFOLS, IMMUCOR, NANOSPHERE, ORTHO-CLINICAL DIAGNOSTIC, ROCHE, SARSTEDT, SIEMENS, TECAN AND OTHER SUPPLIERS

VI. MAJOR IN VITRO DIAGNOSTIC TECHNOLOGIES AND THEIR POTENTIAL APPLICATIONS

1. Molecular Diagnostics
  a. Overview
  b. NAT
2. Monoclonal and Polyclonal Antibodies
3. Immunoassays
  a. Technological Principle
  b. Chemiluminescence
  c. Enzyme Immunoassays (EIA)
    Overview
    ELISA
    EMIT
    Electrochemical
  d. Radioimmunoassays (RIA)
  e. Immunoprecipitation
  f. Affinity Chromatography
4. Microtitration Plates
5. IT and Automation
6. Lasers
7. Robotics
8. Synthetic Red Cell Substitutes
9. Genetically Engineered Blood Components
  a. Albumin
  b. Factor VIII
  c. Alpha-2 Antiplasmin
  d. Antithrombin III
  e. Factor IX
  f. Von Willebrand's Factor
  g. Fibrinogen
  h. t-PA
10. Blood Preservation
11. Autologous Blood Transfusion/Freezing

VII. COMPETITIVE ASSESSMENTS

    Abbott
    Beckman Coulter/Danaher
    Becton Dickinson
    Biokit
    BioMerieux
    Bio-Rad
    Diagast
    DiaSorin
    Fujirebio
    Hologic/Gen-Probe
    Grifols
    Immucor
    Innogenetics
    Ortho-Clinical Diagnostics
    Orchid CellMark
    Novartis Diagnostics
    Proteome Sciences
    Roche
    Siemens
    Tecan

List Of Tables

LIST OF TABLES

Major Companies Developing or Marketing Blood Typing and Grouping Tests
Major Companies Developing or Marketing HLA Typing Tests
Major Companies Developing or Marketing AIDS Tests
Major Companies Developing or Marketing Hepatitis Tests
Major Companies Developing or Marketing CMV Tests
Major Companies Developing or Marketing Syphilis Tests
Major Companies Developing or Marketing Blood Bank Analyzers
Worldwide, All Market Segments, Facilities Performing Blood Bank Tests By Country
Worldwide, All Market Segments, Total Blood Typing and Grouping Test Volume Forecast By Country
Worldwide, All Market Segments, Total Infectious Disease Screening Test Volume Forecast
Worldwide, All Market Segments, Total Blood Typing and Grouping Reagent Market Forecast By Country
Worldwide, All Market Segments, Total Infectious Disease Reagent Market Forecast By Country